Green Banana (GB) Mixed Diet in the Management of Persistent Diarrhea (PD)

NCT ID: NCT03366740

Last Updated: 2021-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

135 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-12-07

Study Completion Date

2021-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Diarrhea is the 2nd leading cause of death in under-five children. When diarrhea continued for 14 days or more it is known as Persistent Diarrhea (PD). In low and middle income countries (LMIC), 3%-23% of acute diarrheal episodes turn to PD. PD causes 32-62% of all diarrheal deaths in LMIC, and \>25% in Bangladesh in contrast to 0.8% is caused by acute diarrhea. The prevalence of PD varied from 6.3 to 16.4 %. However, no larger prospective study was conducted to evaluate the efficacy of green banana in the management of PD among children older than 6 months.An open-labeled randomized controlled clinical trial is designed to assess the efficacy of green banana mixed full strength rice suji, and full strength rice suji alone compared to 3/4th strength rice suji in the management of persistent diarrhea (PD) in children aged \> 6 months to 36 months in the Dhaka Hospital of icddr,b.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Background:

Diarrhea, defined as passage of loose or watery stool 3 times or more in a 24 hour period, is the 2nd leading cause of death in under-five children. It accounts for 531,000 deaths among 5.9 million globally and 7,140 deaths among 119,000 Bangladeshi under-five deaths in 2015. Countries of Africa and South-East Asia, particularly India, Nigeria, Congo, Afghanistan, Pakistan, Ethiopia and Bangladesh face around 80% of total diarrhea related death of the world. Use of ORS and zinc reduced the number of diarrheal deaths, especially from acute diarrhea to 0.8%. However, when diarrhea continued for 14 days or more and which does not include recurrent or chronic diarrhea, such as coeliac disease, cystic fibrosis or congenital diarrheal disorders, it is known as persistent diarrhea (PD). In low and middle income countries 3%-23% of acute diarrheal episodes turn to PD. PD has been responsible for 30-62%, diarrhea associated deaths of young children in low- and middle- income countries. And in Bangladesh, PD accounted for more than 25% of all diarrhea related deaths among children aged 1-4 years and 40% of them were found malnourished.An international working group had developed and tested an algorithm through a multi country cohort for the treatment of PD nearly twenty years ago.However, this stepwise dietary algorithm increases the duration of hospital stay. To reduce the osmotic burden frequently children are given 3/4th strength diet. Though these diets are iso-osmolar, they provide suboptimal energy to the children. Several studies demonstrated the beneficial effect of green banana (GB) (whole green banana fruit, Musa paradisiacal sapientum) in the resolution of PD.The anti-diarrheal action of GB is postulated to be mediated by its high content of amylase-resistant starch (ARS), which is not digested in the small intestine of humans. On reaching the colon, it is fermented by resident bacteria into the short-chain fatty acids (SCFA) butyrate, propionate, and acetate. In the colon, SCFA stimulate salt and water absorption as well as provide energy and induce a trophic effect on the colonic as well as small-bowel mucosa. As 3/4th strength rice suiji is not providing sufficient calorie we are proposing to give full-strength rice suji as one intervention, and to ascertain the efficacy of GB in children suffering from undernutrition and/or co-morbidities we are proposing to give GB mix full strength rice suiji as another intervention.

Study design: This will be an open-labeled randomized controlled clinical trial with three treatment arms (3/4th strength rice suji, full strength rice suji with modification and GB mixed full strength rice suji). Investigators will prospectively screen, children \> 6 to 36 months of age admitted to the Dhaka hospital of icddr,b, with PD or developed PD during their treatment period and failed to respond with milk suji and enroll them for the study. Thereafter permuted block randomization technique will be followed to select treatment arms for each child.

Study Area: The study will be conducted at the Dhaka hospital of the International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.This hospital provides care and treatment to over 140,000 patients annually of all ages and either sex, among them the number of under-five children were 83285. For critically ill patients there is an intensive care unit (ICU) facility present within the hospital, equipped with necessary life support measures including mechanical ventilators, syringe pump for vasopressor support.

Clinical management:

Usually children having PD will be admitted to the longer stay unit of the Dhaka hospital. An initial routine investigation will be done by the treating unit to identify the etiology of diarrhea whether infectious or noninfectious by doing stool RE and RS; TC, DC, Hb%. If stool RE suggestive of invasive diarrhea, appropriate antibiotic will be provided according to hospital protocol. During this period, milk suji, a low lactose diet, will be given as a routine diet. If child's PD resolved with milk suji, the child will be discharged with common health related advices. On day 4 (3 days after milk suji), if PD doesn't resolve, the child will be enrolled in the study and randomization will be done. The child will get either of the three diets- green banana mixed full strength rise suji, full strength rice suji, or 3/4th strength rice suji. With any of these diets, a child will be followed for 7 days. If there is deterioration of diarrhea (either increased frequency or watery consistency) for 3 days or condition remains static up to 7 days the child will be declared as treatment failure. Because this study duration will be for 7 days, after these one week of management, the child will not remain in the study and will receive standard management of the Dhaka hospital of icddr,b.

Sample size:

With 80 % power and 5% type I error and considering three treatment arms, Investigators need 40 children in each arm. If 45 children is enrolled in each arm,it will be able to accommodate up to 11 % attrition

So, the total sample size = 45\*3= 135

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Persistent Diarrhea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Study design: This will be an open-labeled randomized controlled clinical trial with three treatment arms (3/4th strength rice suji, full strength rice suji with modification and GB mixed full strength rice suji). Investigators will prospectively screen, children \> 6 to 36 months of age admitted to the Dhaka hospital of icddr,b, with PD or developed PD during their treatment period and failed to respond with milk suji and enroll them for the study. Thereafter permuted block randomization technique will be followed to select treatment arms for each child.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

GB mixed full strength rice suji

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get the GB mixed full strength rice suji.

The allocated diet will be continued for 7 days and a child will be followed. If there is deterioration of diarrhea (either increased frequency or watery consistency) for 3 days or condition remains static up to 7 days the child will be declared as treatment failure.

Group Type EXPERIMENTAL

GB mixed full strength rice suji

Intervention Type OTHER

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get the Green banana mixed full strength rice suji The diet will be continued for 7 days and a child will be followed. If there is deterioration of diarrhea (either increased frequency or watery consistency) for 3 days or condition remains static up to 7 days the child will be declared as treatment failure.

Full strength rice suji alone

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get full strength rice suji alone.

Group Type EXPERIMENTAL

Full strength rice suji Alone

Intervention Type OTHER

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get full strength rice suji alone.

The diet will be continued for 7 days and a child will be followed. If there is deterioration of diarrhea (either increased frequency or watery consistency) for 3 days or condition remains static up to 7 days the child will be declared as treatment failure.

3/4th strength rice suji

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get 3/4th strength rice suji.

Group Type ACTIVE_COMPARATOR

3/4th strength rice suji

Intervention Type OTHER

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get 3/4th strength rice suji.

The diet will be continued for 7 days and a child will be followed. If there is deterioration of diarrhea (either increased frequency or watery consistency) for 3 days or condition remains static up to 7 days the child will be declared as treatment failure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GB mixed full strength rice suji

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get the Green banana mixed full strength rice suji The diet will be continued for 7 days and a child will be followed. If there is deterioration of diarrhea (either increased frequency or watery consistency) for 3 days or condition remains static up to 7 days the child will be declared as treatment failure.

Intervention Type OTHER

Full strength rice suji Alone

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get full strength rice suji alone.

The diet will be continued for 7 days and a child will be followed. If there is deterioration of diarrhea (either increased frequency or watery consistency) for 3 days or condition remains static up to 7 days the child will be declared as treatment failure.

Intervention Type OTHER

3/4th strength rice suji

On day 4 (3 days after milk suji) after diagnosis of PD, if PD doesn't resolve, the child will be enrolled in the study and after randomization will get 3/4th strength rice suji.

The diet will be continued for 7 days and a child will be followed. If there is deterioration of diarrhea (either increased frequency or watery consistency) for 3 days or condition remains static up to 7 days the child will be declared as treatment failure.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Children aged \> 6 to 36 months, having diarrhea for 14 days or more (up to 29 days) either at admission or developed at some point during their treatment period in hospital
* Children able to take oral feeds at the time of randomization

Exclusion Criteria

* Children whose parents/care givers do not provide consent
* Growth of Shigella, Salmonella or Cholera in rectal swab culture
* Children having WLZ/WHZ \< -5 SD or +++ edema
* The children presented with septic shock, convulsion or any other illness that needs ICU support during the admission
* Birth defect like complex congenital heart diseases, cleft lip and cleft palate, Down syndrome and cerebral palsy and others that may itself cause digestive problem or failing to thrive
* Children diagnosed as having apparent or known tuberculosis or HIV or chronic (\> 30 days)/organic diarrhea (where the cause is known e.g. crohn's disease, ulcerative colitis, celiac disease etc.)
Minimum Eligible Age

6 Months

Maximum Eligible Age

36 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Monira Sarmin, MBBS

Role: PRINCIPAL_INVESTIGATOR

Medical officer, ICU

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dhaka Hospital, icddr,b

Dhaka, , Bangladesh

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Bangladesh

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Monira Sarmin, MBBS

Role: CONTACT

01718596947 ext. 2303

Md I Hossain, PhD

Role: CONTACT

01711071075 ext. 2351

References

Explore related publications, articles, or registry entries linked to this study.

Sarmin M, Hossain MI, Islam SB, Alam NH, Sarker SA, Islam MM, Chisti MJ, Islam SMR, Mahfuz M, Ahmed T. Efficacy of a Green Banana-Mixed Diet in the Management of Persistent Diarrhea: Protocol for an Open-Labeled, Randomized Controlled Trial. JMIR Res Protoc. 2020 Mar 6;9(3):e15759. doi: 10.2196/15759.

Reference Type DERIVED
PMID: 32224490 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PR-17075

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Zinc Sulfate Acceptability
NCT04039828 COMPLETED NA
Zinc Supplementation in Shigella Patients
NCT00321126 COMPLETED PHASE3